| High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer J Calais, B Dubray, L Nkhali, S Thureau, C Lemarignier, R Modzelewski, ... European journal of nuclear medicine and molecular imaging 42, 858-867, 2015 | 41 | 2015 |
| Fully versus partially covered self-expandable metal stents in benign esophageal strictures A Gangloff, S Lecleire, A Di Fiore, E Huet, I Iwanicki-Caron, M Antonietti, ... Diseases of the Esophagus 28 (7), 678-683, 2015 | 27 | 2015 |
| How to interpret multidimensional quality of life questionnaires for patients with schizophrenia? P Michel, P Auquier, K Baumstarck, A Loundou, B Ghattas, C Lançon, ... Quality of Life Research 24, 2483-2492, 2015 | 14 | 2015 |
| Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients P Michel, P Auquier, K Baumstarck, J Pelletier, A Loundou, B Ghattas, ... Quality of Life Research 24, 2261-2271, 2015 | 6 | 2015 |
| Nutrition artificielle et radio-chimiothérapie P Déchelotte, P Michel, E Lerebours Nutrition clinique et métabolisme 11 (4), 396-400, 1997 | 5 | 1997 |
| Clinical interest of digital PCR for routine detection of circulating DNA in metastatic colorectal cancer D Sefrioui, C Vasseur, R Sesboué, F Blanchard, A Gangloff, M Baretti, ... Annals of Oncology 25, iv559, 2014 | 3 | 2014 |
| Chimiothérapie adjuvante du cancer gastrique P Michel, F Di Fiore Gastroentérologie Clinique et Biologique 30 (1), 96-101, 2006 | 1 | 2006 |
| BLEEDING PEPTIC-ULCER IN PATIENTS AGED OVER 80 YEARS-INCIDENCE AND PROGNOSIS P Hochain, C Capet, V Merle, P Michel, G Riachi, P DUCROTTE, ... GASTROENTEROLOGY 108 (4), A116-A116, 1995 | 1 | 1995 |
| Poste D Michel La Grande Encyclopédie 16, 9777-9781, 0 | 1 | |
| Circulating Tumor Cells and Circulating Tumoral DNA in Diagnosis of Pancreatic Tumor C Dolphus, P Basile, F Blanchard, D Sefrioui, M Paresy, ... LABORATORY INVESTIGATION 95, 157A-158A, 2015 | | 2015 |
| Adjuvant therapy in colorectal cancer: aspirin, a targeted therapy? C Sibertin-Blanc, L Dahan, P Michel, JF Seitz Oncologie 16, 509-515, 2014 | | 2014 |
| Development of computerized adaptive test (CAT) item bank for assessing quality of life in multiple sclerosis: preliminary results from a european multi-center study P Michel, K Baumstarck, M Boucekine, L Boyer, A Loundou, J Pelletier, ... QUALITY OF LIFE RESEARCH 23, 73-74, 2014 | | 2014 |
| Impact de la biologie moleculaire sur la prise en charge des cancers digestifs JF Seitz, P Michel Hépato-Gastro & Oncologie Digestive 21 (7), 477-480, 2014 | | 2014 |
| A Bar Code of Selected Gene Copy Number Alterations is Associated with Disease-Free Survival in Stage Ii-Iii Microsatellite Stable (Mss) Colon Cancer F Di Fiore, L Armengol-Debeir, F Blanchard, C Chapusot, B Tournier, ... Annals of Oncology 25, iv193, 2014 | | 2014 |
| The 70% of SUVmax threshold on pre radiotherapy PET/CT identifies the site of local recurrence in lung cancer J Calais, B Dubray, L Nkhali, S Thureau, C Lemarignier, R Modzelewski, ... Annual meeting of the European Society for Radiotherapy and Oncology, 2014 | | 2014 |
| Les essais thérapeutiques PRODIGE en cours S MANFREDI, P MICHEL, D MALKA, J BENNOUNA La Lettre du cancérologue (Boulogne) 23 (5), 164-167, 2014 | | 2014 |
| FDG-PET/CT during chemo-radiotherapy for esophageal cancer: Planning higher radiotherapy doses to reduced target volumes L Nkhali, S Thureau, A Edet-Sanson, K Doyeux, A Benyoucef, I Gardin, ... EUROPEAN JOURNAL OF CANCER 49, S602-S602, 2013 | | 2013 |
| Autres biomarqueurs potentiels des anti-EGFR F Di Fiore, P Michel Médecine personnalisée en cancérologie digestive, 177-191, 2013 | | 2013 |
| Détermination de la valeur prédictive de la TEP-FDG en cours de RCT pour cancer de l’œsophage par une méthode d’imagerie paramétrique O Palie, P Michel, C Rousseau, ME Meyer, S Bardet, P Olivier, E Itti, ... Medecine Nucleaire 5 (37), 136-137, 2013 | | 2013 |
| Optimisation balistique de la radiothérapie selon la TEP/TDM-FDG réalisée en cours de radio-chimiothérapie (RTCT) concomitante pour cancer de l’œsophage L Nkhali, S Thureau, A Edet-Sanson, K Doyeux, A Benyoucef, I Gardin, ... Medecine Nucleaire 5 (37), 162, 2013 | | 2013 |
